Education and Training
- Fellow in Hematology and Oncology, Medicine, Mount Sinai School of Medicine, 2004 - 2007
- Medical Resident, Medicine, Mount Sinai School of Medicine, 2001 - 2004
- M.D., University of Medicine and Dentistry of New Jersey, 2001
Bestvina, CM, Zullig, LL, Rushing, C, Chino, F, Samsa, GP, Altomare, I, Tulsky, J, Ubel, P, Schrag, D, Nicolla, J, Abernethy, AP, Peppercorn, J, and Zafar, SY. "Patient-oncologist cost communication, financial distress, and medication adherence." Journal of oncology practice 10, no. 3 (May 2014): 162-167.
Showalter, K, Maize, J, Altomare, I, and Fisher, G. "Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during mohs micrographic surgery." Dermatology Online Journal 19, no. 8 (August 21, 2013).
Uronis, HE, Bendell, JC, Altomare, I, Blobe, GC, Hsu, SD, Morse, MA, Pang, H, Zafar, SY, Conkling, P, Favaro, J, Arrowood, CC, Cushman, SM, Meadows, KL, Brady, JC, Nixon, AB, and Hurwitz, HI. "A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas." Oncologist 18, no. 3 (2013): 271-272.
Altomare, I, and Hurwitz, H. "Everolimus in colorectal cancer." Expert Opinion on Pharmacotherapy 14, no. 4 (2013): 505-513.
Showalter, K, Jr, JM, Altomare, I, and Fisher, G. "Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during mohs micrographic surgery." Dermatology Online Journal 19, no. 8 (2013).
Altomare, I, Wasser, J, and Pullarkat, V. "Bleeding and mortality outcomes in ITP clinical trials: A review of thrombopoietin mimetics data." American Journal of Hematology 87, no. 10 (2012): 984-987.
Altomare, I, Bendell, JC, Bullock, KE, Uronis, HE, Morse, MA, Hsu, SD, Zafar, SY, Blobe, GC, Pang, H, Honeycutt, W, Sutton, L, and Hurwitz, HI. "A phase II trial of bevacizumab plus everolimus for patients with refractory metastatic colorectal cancer." Oncologist 16, no. 8 (2011): 1131-1137.
Hilari, JM, Mangas, C, Xi, L, Paradelo, C, Ferrándiz, C, Hughes, SJ, Yueh, C, Altomare, I, Gooding, WE, and Godfrey, TE. "Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time RT-PCR." Annals of Surgical Oncology 16, no. 1 (2009): 177-185.
Altomare, I, Adler, A, and Aledort, LM. "The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: A case series and review of the literature." Thrombosis Journal 5 (2007).
Altomare, I, Desman, G, and Aledort, LM. "Echinocytosis - An unusual manifestation of hemangioma." American Journal of Hematology 81, no. 7 (2006): 532-534.